# Acrivon Therapeutics

**Canonical:** https://apis.io/providers/acrivon-therapeutics/  
**Website:** https://acrivon.com  
**APIs profiled:** 1

Acrivon Therapeutics is a clinical‑stage oncology company leveraging its proprietary Acrivon Predictive Precision Proteomics (AP3) platform to develop targeted therapies. The company focuses on precision medicine, creating companion diagnostics and drug candidates such as ACR‑368 (prexasertib), ACR‑2316, and ACR‑7280, aiming to improve patient outcomes across diverse tumor alterations.

## Kin Score — 9.4 / 100 (minimal)

Scored 2026-10-31 under rubric 0.25.0.

| Facet | Score |
|---|---|
| Discoverability | 53.6 |
| Contract Quality | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Access Clarity | 21.1 |

Regulatory layer — **Horizontal (data, software, accessibility, platform)**: 13.7 (matched via fallback).

## Agent readiness — 3.1 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | documented |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |
| Pagination Ratio | na |
| Operation Distinctiveness | na |

## APIs (1)

- **Acrivon API** — Acrivon Therapeutics does not expose a public API; no machine‑readable specification was found on its website or developer portal.

## Security (1)

- **Acrivon Therapeutics Domain Security** — TLSv1.3 · DNSSEC · DMARC

## Tags

Company, Oncology, Biotechnology, Precision Medicine, Therapeutics

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/acrivon-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.
